1. Home
  2. LSTA vs LITB Comparison

LSTA vs LITB Comparison

Compare LSTA & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • LITB
  • Stock Information
  • Founded
  • LSTA 1980
  • LITB 2007
  • Country
  • LSTA United States
  • LITB Singapore
  • Employees
  • LSTA N/A
  • LITB N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • LITB Catalog/Specialty Distribution
  • Sector
  • LSTA Health Care
  • LITB Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • LITB Nasdaq
  • Market Cap
  • LSTA 22.5M
  • LITB 21.1M
  • IPO Year
  • LSTA N/A
  • LITB N/A
  • Fundamental
  • Price
  • LSTA $2.72
  • LITB $1.31
  • Analyst Decision
  • LSTA Strong Buy
  • LITB
  • Analyst Count
  • LSTA 1
  • LITB 0
  • Target Price
  • LSTA $15.00
  • LITB N/A
  • AVG Volume (30 Days)
  • LSTA 23.5K
  • LITB 10.8K
  • Earning Date
  • LSTA 08-11-2025
  • LITB 08-01-2025
  • Dividend Yield
  • LSTA N/A
  • LITB N/A
  • EPS Growth
  • LSTA N/A
  • LITB N/A
  • EPS
  • LSTA N/A
  • LITB 0.08
  • Revenue
  • LSTA $1,000,000.00
  • LITB $231,136,000.00
  • Revenue This Year
  • LSTA N/A
  • LITB N/A
  • Revenue Next Year
  • LSTA N/A
  • LITB N/A
  • P/E Ratio
  • LSTA N/A
  • LITB $16.55
  • Revenue Growth
  • LSTA N/A
  • LITB N/A
  • 52 Week Low
  • LSTA $1.87
  • LITB $0.91
  • 52 Week High
  • LSTA $4.20
  • LITB $4.98
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 52.43
  • LITB 57.98
  • Support Level
  • LSTA $2.34
  • LITB $1.22
  • Resistance Level
  • LSTA $3.09
  • LITB $1.34
  • Average True Range (ATR)
  • LSTA 0.25
  • LITB 0.08
  • MACD
  • LSTA 0.01
  • LITB 0.02
  • Stochastic Oscillator
  • LSTA 50.67
  • LITB 82.76

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: